Viewing nowProivan Tablet 150 mg (Ibandronic Acid Monohydrate)
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

MFDS item code 201207294 · Approved 2012.10.18 · Insurance code 657202450
Treatment of osteoporosis in postmenopausal women
This medication is used to prevent and treat osteoporosis that may occur in postmenopausal women. It helps to increase bone density, reduce the risk of fractures, and improve bone health. Consistent use can improve complications resulting from osteoporosis.
Take 1 tablet once a month, regularly, in the morning on the same day each month, with plenty of water at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium): - This medicine must be swallowed with a sufficient amount (180-240ml) of water while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take a dose on the scheduled day - If 8 days or more remain until the next scheduled dose, take 1 tablet the morning after realizing that you missed the dose, and thereafter take 1 tablet each month on the originally scheduled day. - If 7 days or fewer remain until the next scheduled dose, take 1 tablet on the next scheduled day, and thereafter take 1 tablet each month on the originally scheduled day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required for patients with mild or moderate renal impairment and a creatinine clearance of 30mL/min or higher. As clinical experience in patients with a creatinine clearance of less than 30mL/min is insufficient, administration of this medicine is not recommended. Older adults No dose adjustment is required.
Efficacy and safety in children 18 years of age or younger have not been studied.
This medication should not be used by certain patients. For example, individuals allergic to this medication or its components, patients with untreated hypocalcemia, those unable to sit or stand upright for at least 60 minutes, individuals with esophageal function problems that impede swallowing, and those with lactose intolerance or certain genetic metabolic disorders should not take this medication. In cases of severe renal impairment, the administration of this medication should be done with caution, following a doctor's instructions. Adverse effects such as gastrointestinal discomfort, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur upon taking this medication. Particularly during initial administration, flu-like symptoms may temporarily appear, so caution is advised. Severe esophageal issues such as esophagitis, esophageal ulcers, and esophageal erosion may arise, necessitating that patients remain upright or standing for at least 60 minutes after taking this medication. If difficulty swallowing or chest pain occurs, take this medication immediately and consult a doctor. Bisphosphonate medications may cause serious side effects such as osteonecrosis of the jaw, so consult your doctor before any dental treatments, and avoid excessive dental treatment while taking this medication. Additionally, this medication may have impaired absorption when taken with food, calcium, aluminum, magnesium, iron, or other components, so other medications or foods should not be consumed for at least 1 hour after taking this medication. It is safest for pregnant or nursing women to avoid this medication, and safety and efficacy have not been established for children under 18 years of age. In case of overdose, gastrointestinal disturbances or hypocalcemia may occur, so strict adherence to the prescribed dosage is essential, and medical attention should be sought immediately if symptoms arise. Lastly, keep this medication out of the reach of children and dispose of expired medications properly to avoid environmental harm.
Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, asthma exacerbation, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical subtrochanteric fracture, mid femoral fracture, paresthesia of the eye, weakness, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is essential to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's effectiveness for a long period.
White to almost white rectangular film-coated tablet
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.